![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
GlaxoSmithKline will begin trials of its arthritis drug in COVID-19 patients at the end of the month. The drug, otilimab, will be tested on patients suffering from pneumonia related to coronavirus. About 800 patients...
[column] 50 quick fixes om je onsite seo te verbeteren
Het internet staat bol van de tips & tricks om je vindbaarheid te verbeteren. Veel daarvan zijn prima, maar de ontwikkelingen en updates in Google volgen elkaar razendsnel op.
[column] Recovery Marketing #2: hoog en laag budgetmarketing
Er zijn nu grofweg twee typen marketeers: met budget of zonder. Beide groepen kunnen hun marktaandeel versterken in deze periode maar hebben wel een flink andere route.
Design tijdens corona: ‘Never waste a good crisis’
MarketingTribune in gesprek met Tom Dorresteijn, CEO designbureau Studio Dumbar (part of Dept), over de gevolgen van de coronacrisis voor zijn bureau.
ACE inhibitors should not be discontinued over fears about COVID-19, say researchers
Researchers in Europe have found no evidence to support previous reports that the use of drugs that target the renin-angiotensin-aldosterone system (RAAS) increases susceptibility to coronavirus disease 2019 (COVID-19)...
Experts advise not to make COVID-19 crisis worse by rushing for cures
People have died from overdoses of unproven cures in past pandemics. In an editorial published today in Australian Prescriber, Associate Professor Darren Roberts from St Vincent’s Hospital in Sydney and Dr Alexandra...
Rubius begins patient dosing in phase 1/2 trial of RTX?240 to treat r/r locally advanced solid tumors
Rubius Therapeutics, a clinical─stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines, announced that the first patient
Study: Scant proportion of hospitalized patients with opioid use disorder receive treatment
Despite a national opioid-related overdose epidemic that continues to claim tens of thousands of lives annually, a new nationwide study shows that a scant proportion of hospitalized patients with opioid use disorder...
Novel anti-cancer medicine could improve current therapy for ER+ breast cancer
The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive breast cancer – the most common form of breast cancer in Australia – according to preclinical studies led...
BERG, Boehringer Ingelheim ink research collaboration to identify candidate biomarkers for a group of inflammatory conditions
BERG, a clinical─stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, announced
Fitnessbranche al wel digitaal, maar verdient er niets mee
Sportscholen en fitnesscentra kunnen vanwege corona nog niet meteen open, doch het merendeel verdient nauwelijks iets met hun digitale workouts. Dat blijkt uit onderzoek van Virtuagym, technologieaanbieder voor...
Remote monitoring of COVID-19 patients using AI device
Using AI device Massachusetts’ Institute of Technology (MIT) at its Computer Science and Artificial Intelligence Laboratory (CSAIL) has developed a device that can monitor patients with the highly infective COVID...
Oncological care in the COVID-19 era
Oncological care In Nature Medicine, the seven comprehensive cancer centres of Cancer Core Europe, including the Netherlands Cancer Institute and Cancer Research UK Cambridge Centre, have shared how they rapidly...
Infographic: de techtrends voor 2020
Techtrends voor 2020 Wat worden de techtrends voor 2020? We zitten nog vroeg in het jaar, dus het kan nog alle kanten op. Het team van SimForm ziet in elk geval (nieuwe) kansen voor kunstmatige intelligentie...
Don’t count on a COVID-19 vaccine for at least five years, says AI-based forecast
COVID-19 vaccine Could a COVID-19 vaccine really be ready in 12 to 18 months? Global analytics firm Clarivate applied machine learning to leading vaccine candidates from Moderna and Inovio and made some sobering...
How to Define a Workflow That Keeps Content Production On Track
Content Production Is your content often delivered late? Do you have trouble getting it signed off? Does it typically get stuck in limbo? If you’re nodding your head, your content team probably hasn’t defined its...
Waarom B2B-bedrijven hun marketing ballen moeten tonen tijdens de coronacrisis
Coronacrisis De manier waarop je als B2B-ondernemer op de coronacrisis reageert, is sterk afhankelijk van je financiële slagkracht. Maar wat als je nu stopt met marketing en branding? Welke omzet loop je dan over één of...
[whitepaper] Tips om je mailingstatistieken te verbeteren
Mailingstatistieken Het klinkt zo lekker cliché, maar het blijft een feit: meten is weten en weten is verbeteren. De drie ratio’s waarmee je in de e-mail marketing rekening houdt, zijn op te delen in aflevering...
